FOR IMMEDIATE RELEASE
(847) 746-4317 or (224) 545-4290 (cell)
Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center Receives 2016 Press Ganey Guardian of Excellence Awards for Outstanding Performance in Patient Experience
Chicago, Ill. – (November 14, 2016) – Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) is pleased to announce that it has been named as a 2016 Guardian of Excellence Award® winner by Press Ganey for inpatient services. The Guardian of Excellence Award recognizes top-performing health care organizations that have consistently achieved the 95th percentile or above of performance in Patient Experience.
“Receiving this award reinforces our core belief that it takes an entire team of dedicated healthcare professionals to deliver outstanding patient-centered care,” said Jacklynn Lesniak, Senior Vice President of Patient Care Services and Chief Nursing Officer at Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern). “Everyone one plays a critical part in the delivery of excellent care, no matter their role.”
The Press Ganey Guardian of Excellence Award is a nationally-recognized symbol of achievement in health care. Presented annually, the award honors clients who consistently sustained performance in the top 5% of all Press Ganey clients for each reporting period during the course of one year.
“We salute our team members for demonstrating the outstanding care and patient experience that our CTCA patients so strongly believe in and embrace,” said Anne Meisner, CEO of Southeastern and Chief of Hospital Operations for all CTCA locations. “We are incredibly proud of the dedication and level of overall quality care that each of our Stakeholders provides to our patients and their families every day.”
According to Meisner, the award represents an important recognition from the industry’s leader in measuring, understanding and improving patient experience.
"We are proud to partner with CTCA,” said Patrick T. Ryan, CEO of Press Ganey. “This award is a testament to the organization’s leadership in delivering patient-centered care. By achieving and sustaining this level of excellence, CTCA continues to demonstrate their commitment to reducing patient suffering and advancing the overall quality of health care.”
Additional CTCA® hospitals that were recognized include: Atlanta (Southeastern) for inpatient services, Phoenix (Western) and Tulsa (Southwestern) for excellence in outpatient care. The Atlanta and Tulsa hospitals also received the Guardian of Excellence award in 2015.
About Press Ganey
Press Ganey is a leading provider of patient experience measurement, performance analytics and strategic advisory solutions for health care organizations across the continuum of care. With over 30 years of experience, Press Ganey is recognized as a pioneer and thought leader in patient experience measurement and performance improvement solutions. Our mission is to help health care organizations reduce patient suffering and improve clinical quality, safety and the patient experience. As of January 1, 2016, Press Ganey served more than 26,000 health care facilities. For more information, visit www.pressganey.com.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.